Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ASP7991 Clinical Pharmacological Study -Examination of Pharmacokinetics and Pharmacodynamics in Chronic Kidney Disease Patients Undergoing Hemodialysis

NCT01872026 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT01872026
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01872026 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ASP7991 Clinical Pharmacological Study -Examination of Pharmacokinetics and Pharmacodynamics in Chronic Kidney Disease Patients Undergoing Hemodialysis
Lead sponsor
Astellas Pharma Inc
Phase
Phase 1
Overall status
Completed
Start date
December 26, 2012
Completion date
June 26, 2013
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patients on stable chronic maintenance dialysis who are receiving hemodialysis therapy, pharmacodynamics of asp7991, pharmacokinetics of asp7991